John W Smither

John W Smither has an estimated net worth of $9.34 Million. This is based on reported shares across multiple companies, which include KYTHERA BIOPHARMACEUTICALS INC, Arcutis Biotherapeutics, Inc., Applied Molecular Transport Inc., eFFECTOR Therapeutics, Inc., Principia Biopharma Inc., Sienna Biopharmaceuticals, Inc., Achaogen Inc, GENELUX Corp, NewAmsterdam Pharma Co N.V., and MBX Biosciences, Inc..

2014 was John W Smither's most active year for acquiring shares with 17 total transactions. John W Smither's most active month to acquire stocks was the month of December. 2015 was John W Smither's most active year for disposing of shares, totalling 38 transactions. John W Smither's most active month to dispose stocks was the month of August. 2015 saw John W Smither paying a total of $1,582,798.88 for 182,219 shares, this is the most they've acquired in one year. In 2015 John W Smither cashed out on 283,526 shares for a total of $5,839,214.88, their largest year based on trade value.